| Item | Obligations |
|---|---|
| FY21 | $5.6B |
| FY22 | $494K |
| FY23 | $326M |
| FY24 | $0 |
| FY25 | -$332M |
| FY26 | $279M |
Regeneron Pharmaceuticals won $279M in FY2026 to date.
| Item | Obligations |
|---|---|
| FY21 | $5.6B |
| FY22 | $494K |
| FY23 | $326M |
| FY24 | $0 |
| FY25 | -$332M |
| FY26 | $279M |
Regeneron Pharmaceuticals won $279M in FY2026 to date.